Anticoagulation strategy in patients with atrial fibrillation after carotid endarterectomy

dc.contributor.authorUgurlucan, Murat
dc.contributor.authorAkay, Hakki Tankut
dc.contributor.authorErdinc, Ibrahim
dc.contributor.authorOztas, Didem Melis
dc.contributor.authorConkbayir, Cenk
dc.contributor.authorAslim, Erdal
dc.contributor.authorYildiz, Cenk Eray
dc.contributor.authorAydin, Kubilay
dc.contributor.authorAlpagut, Ufuk
dc.contributor.pubmedID30189792en_US
dc.date.accessioned2020-12-26T10:30:19Z
dc.date.available2020-12-26T10:30:19Z
dc.date.issued2019
dc.description.abstractAim: Carotid artery stenosis and atrial fibrillation are diseases of the aging patient population. Literature lacks precise anticoagulation treatment protocols for patients with atrial fibrillation following carotid endarterectomy. We present our experiences with anticoagulation strategy in this particular patient population.Patients and methods: Between June 2001-September 2017, 165 patients with chronic or paroxysmal atrial fibrillation out of 1594 cases from three different institutions whom received Coumadin and aspirin and required carotid endarterectomy were reviewed, respectively. Mean age was 63.47.9 years. Male/female ratio was 102/63. There were 67 diabetic and 138 hypertensive cases.Results: Patients are followed a mean of 64.4 +/- 16.9 months. Early mortality occurred in two patients due to intracranial bleeding and heart failure. Another patient was lost due to intracerebral hemorrhage and 16 other patients died due to various causes in the late follow-up. Three patients required exploration against bleeding.Conclusion: Combination of warfarin with an aim to keep the INR value between 2 and 3, and aspirin at a dosage of 100mg per day seemed feasible and in our modest patient cohort. Further studies including multicenter larger data are warranted in order to establish a precise anticoagulation treatment protocol for patients with atrial fibrillation after carotid endarterectomy.en_US
dc.identifier.endpage216en_US
dc.identifier.issn0001-5458en_US
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85053348273en_US
dc.identifier.startpage209en_US
dc.identifier.urihttp://hdl.handle.net/11727/5213
dc.identifier.volume119en_US
dc.identifier.wos000472460000001en_US
dc.language.isoengen_US
dc.relation.isversionof10.1080/00015458.2018.1497569en_US
dc.relation.journalACTA CHIRURGICA BELGICAen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCarotid endarterectomyen_US
dc.subjectatrial fibrillationen_US
dc.subjectanticoagulationen_US
dc.titleAnticoagulation strategy in patients with atrial fibrillation after carotid endarterectomyen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: